Search For "non alcoholic fatty liver disease"
Shilpa Medicare Secures SEC-CDSCO Nod for Nor-Ursodeoxycholic Acid Tablets
Updated : 1 year, 2 months ago IST
Raichur (Karnataka) [India], March 12: Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED), a leading API and formulation manufacturer, announces that the Subject Expert Committee (SEC) of CDSCO has approved its Investigational New Drug (IND) - Nor Ursodeoxycholic Acid (Nor UDCA) Tablets
Read More
Sharda University Hosts Successful National Conference on Advances in Medi
Updated : 1 year, 6 months ago IST
Greater Noida (Uttar Pradesh) [India], November 15: School of Medical Sciences and Research (SMS&R) at Sharda Hospital successfully organised the first, National Multidisciplinary Conference on Recent Advances in Medical Specialties at the Anand Swaroop Auditorium, on 13th and 14th Novem
Read More
Zydus and Lupin Sign Licensing Agreement for Co-Marketing Saroglitazar Mg,
Updated : 2 years, 6 months ago IST
Ahmedabad (Gujarat) [India], November 3: Zydus Lifesciences Limited (including its subsidiaries/affiliates hereafter referred to as "Zydus") a discovery-driven, global lifesciences company and Lupin Limited (Lupin), a global pharma major, today announced that they have entered into a licensi
Read More
Study indicates how resistant starch consumption decreases liver triglycer
Updated : 7 months, 3 weeks ago IST
Resistant starch is a nondigestible fibre that ferments in the large intestine and has previously been found to boost metabolism in animal tests. A 4-month randomised controlled experiment in persons with non-alcoholic fatty liver disease (NAFLD) found that regularly eating resistant starch
Read More
Study finds how intake of resistant starch reduces liver triglycerides in
Updated : 2 years, 8 months ago IST
Resistant starch is a nondigestible fibre that ferments in the large intestine, and it has previously been demonstrated in animal experiments to have a favourable effect on metabolism. A 4-month randomised controlled experiment in persons with non-alcoholic fatty liver disease (NAFLD) has fo
Read More
Health Ministry organizes webinar for medical officers of PHCs, district h
Updated : 2 years, 11 months ago IST
The Union Ministry of Health and Family Welfare on Thursday organized a webinar on Non-Alcoholic Fatty Liver Diseases (NAFLD) to empower medical officers of Primary Health Centres (PHCs), Community Health Centres (CHCs) and District Hospitals.
Read More
Metabolic surgery works better than medications for advanced non-alcoholic
Updated : 3 years ago IST
A study has revealed that metabolic (bariatric) surgery is more effective than medications for the treatment of advanced non-alcoholic fatty liver disease.
Read More
Metabolic surgery is more effective than medications for treatment of meta
Updated : 3 years, 1 month ago IST
A study has found that metabolic (bariatric) surgery is more effective than medications for the treatment of advanced non-alcoholic fatty liver disease.
Read More
High sugar and fat diet can cause liver disease: Research
Updated : 3 years, 2 months ago IST
A new study from the University of Missouri School of Medicine has found a correlation between high-fat, high-sugar Western diets and the development of non-alcoholic fatty liver disease, the main cause of chronic liver disease.
Read More
Study reveals antibody therapy for treating liver disease
Updated : 3 years, 3 months ago IST
There is presently no medication available to treat non-alcoholic fatty liver disease, which affects many patients with type 2 diabetes and can lead to other serious liver illnesses. A therapeutic candidate for the treatment of fatty liver has been identified in a study headed by Karolinska
Read More
Increasing coffee consumption may lower the severity of non-alcoholic fatt
Updated : 3 years, 4 months ago IST
A new study, published in Nutrients, from the University of Coimbra discovered that caffeine, polyphenols, and other natural compounds contained in coffee may help lower the severity of non-alcoholic fatty liver disease (NAFLD) in overweight adults with type 2 diabetes (T2D).
Read More
Research: Potential new targets identified in non-alcoholic fatty liver di
Updated : 3 years, 4 months ago IST
Researchers have uncovered novel candidate drug targets for non-alcoholic fatty liver disease (NAFLD) by using the latest technologies, including both single-nuclear sequencing of mice and human liver tissue and advanced 3D glass imaging of mice to characterize key scar-producing liver cells
Read More